PerkinElmer appoints new CEO

Skip to Navigation


  • Published: Aug 23, 2019
  • Source: PerkinElmer
  • Suppliers: PerkinElmer
  • Channels: Gas Chromatography / HPLC / Detectors / Ion Chromatography / Laboratory Informatics / Proteomics & Genomics / Electrophoresis / Sample Preparation / Infrared Spectroscopy / Base Peak / MRI Spectroscopy / NMR Knowledge Base / X-ray Spectrometry / Raman / Chemometrics & Informatics / Proteomics / UV/Vis Spectroscopy / Atomic
thumbnail image: PerkinElmer appoints new CEO

PerkinElmer has announced that after a career of more than 20 years at the company, including the last 12 years as chief executive officer (CEO), Robert Friel has decided to retire as chairman and CEO and member of the board of directors as of the end of the company’s fiscal year on 29 December 2019. After 29 December, Friel will continue as an advisor to the company until 1 March 2020.

Prahlad Singh, president and chief operating officer, has been appointed CEO, effective 30 December 2019. Singh has also been elected as a director of the company. In addition, Alexis Michas, currently serving as lead director, has been elected to serve as non-executive chairman of the board of the company as of 30 December 2019.

“It has been a great honor to serve as PerkinElmer’s CEO over the last 12 years, and I want to express my deep appreciation for the opportunity to work with and learn from so many talented and dedicated colleagues,” said Friel. “The board and I are confident that Prahlad is the right person to take PerkinElmer forward to its next level of success because of his proven ability to build and grow businesses and his deep market knowledge and extensive commercial and operational experience.”

“I would like to thank Rob and the board for this incredible opportunity to lead PerkinElmer in its next phase of growth and value creation,” said Singh. “Since joining PerkinElmer in 2014, I have been privileged to be part of our successful effort to fundamentally change the trajectory of the company’s future. Going forward, I am inspired by the opportunities the company has to build upon Rob’s legacy by continuously innovating and exceptionally serving our customers. Through our commitment to excellence, I believe we will continue to make important and long-term impacts on science and healthcare.”

Social Links

Share This Links

Bookmark and Share


Suppliers Selection
Societies Selection

Banner Ad

Click here to see
all job opportunities

Copyright Information

Interested in spectroscopy? Visit our sister site

Copyright © 2019 John Wiley & Sons, Inc. All Rights Reserved